December 28, 2015
from the American Academy of Dermatology and FDA
FDA proposes age restriction for indoor tanning
SEE BELOW TO ADD YOUR OFFICIAL COMMENT TO THE FDA's PROPOSED RULE.
On December 18, the U.S. Food and Drug Administration (FDA) released a proposal that would place an age-restriction on access to indoor tanning for those under 18 years of age. The American Academy of Dermatology (AAD) applauded the FDA for taking a monumental step to protect the public’s health in the fight against skin cancer.
Recognizing the leadership of the AAD on skin cancer prevention, the FDA notes in its proposal that the AAD “recognizes WHO’s declaration that sunlamp products are cancer-causing agents and are in the same risk category as tobacco, and supports the position that minors should not use sunlamp products.”
Adults who would like to use a tanning bed also would be required to sign a consent form acknowledging the serious health risks of this activity. This is an important step toward educating the public about the dangers associated with indoor tanning.
Indoor tanning is a known contributor to skin cancer, including melanoma (its most deadly form), and other skin damage. Yet, 1.6 million minors indoor tan each year, increasing their risk of skin cancer and other damage (based on data in the 2013 National Youth Risk Behavior Survey).
According to the American Academy of Dermatology, those who have been exposed to radiation from indoor tanning are 59 percent more likely to develop melanoma than those who have never tanned indoors. In addition, the effects of exposure to UV radiation add up over one’s lifetime. Therefore, UV radiation exposure in children and teenagers puts them at a greater risk for skin and eye damage later in life.
We join the ADA in encouraging the FDA to finalize this proposed rule as it would as it would be a historic victory for public health.
How to Comment on the Proposed Rules